Evidence map›Paper›PMID 26980948›Full record

ArticleMediators of inflammation2016

Inhibition of P38 MAPK Downregulates the Expression of IL-1β to Protect Lung from Acute Injury in Intestinal Ischemia Reperfusion Rats.

De-Yi Zheng, Min Zhou, Jiao Jin, Mu He, Yi Wang, Jiao Du, Xiang-Yang Xiao, Ping-Yang Li, Ai-Zhu Ye, Jia Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Role of Atypical MAPK p38 Signaling in the Progression of Influenza A-Induced Acute Lung Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Atypical p38 Signaling, Activation, and Implications for Disease.International journal of molecular sciences · 2021
    Review
  13. Inflammation and Myeloid Cells in Cancer Progression and Metastasis.Frontiers in cell and developmental biology · 2021
    Review
  14. Review
  15. COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

De-Yi ZhengDepartment of Burn and Plastic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Min ZhouInstitute of Neuroscience, Kunming Medical University, Kunming 650031, China; Institute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Jiao JinDepartment of Pediatrics, Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China.
Mu HeInstitute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Yi WangDepartment of Burn and Plastic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Jiao DuDepartment of Burn and Plastic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Xiang-Yang XiaoDepartment of Burn and Plastic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Ping-Yang LiDepartment of Burn and Plastic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Ai-Zhu YeDepartment of Pediatrics, Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China.
Jia LiuInstitute of Neuroscience, Kunming Medical University, Kunming 650031, China; Experimental Animal Center, Kunming Medical University, Kunming 650031, China.
Ting-Hua WangInstitute of Neuroscience, Kunming Medical University, Kunming 650031, China; Institute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu 610041, China; Experimental Animal Center, Kunming Medical University, Kunming 650031, China.
Guizhou Provincial People's Hospital · CNNanyang Medical College · CNSichuan University · CNKunming Medical University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI) induced by intestinal ischemia/reperfusion (II/R) has high incidence and mortality, in which IL-1β was essential for the full development of ALI. However, the detailed regulating mechanism for this phenomenon remains to be unclear. The purpose of this study was to investigate whether inhibition of P38 MAPK could downregulate the expression of IL-1β to protect lung from acute injury in II/R rats. Here, we found that the level of pulmonary edema at 16 hours after operation (hpo) was obviously enhanced compared to that in 8hpo and sham groups. Immunofluorescent staining demonstrated that IL-1β and P38 MAPK were detected in lung tissues. And rats with II/R have the highest translation level for IL-1β and phosphorylation of P38 MAPK in lung tissues at 16hpo compared with 8hpo and sham groups. Moreover, administration of SB239063, an inhibitor of P38 α and β, could effectively downregulate the expressions of IL-1β and protects lung tissues from injury in II/R rats. Our findings indicate that the inhibition of P38 α and β may downregulate the expression of IL-1β to protect lung from acute injury in II/R, which could be used as a potential target for reducing ALI induced by II/R in the future clinical trial.

Indexed as

Acute Lung InjuryAnimalsEnzyme InhibitorsInterleukin-1betaLungMalep38 Mitogen-Activated Protein KinasesPhosphorylationPulmonary EdemaRatsRats, Sprague-DawleyReperfusion InjuryEnzyme InhibitorsInterleukin-1betap38 Mitogen-Activated Protein Kinases

Identifiers

PMID26980948
PMCPMC4766341
OpenAlexW2263775845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.